NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Also, the sponsors and larger parties behind the trials (Genentech in this instance) that get so much attention tend to have many academic and medical allies and to be a source of major dollars for research and other purposes. So they have a high profile, in the circles of those writing about such things. It’s also a social and career circuit, where deep pockets command attention.

Little companies like NWBO are not players in those research circles, the pay for play networking circuits, and charitable funding spaces.... a big conference space once a year can’t compensate for not being relevant to these circles the rest of the year. But that’s not just an NWBO challenge and it usually resolves itself with success.

I would not stay too concerned about it. It’s a bigger issue for shorts to emphasize to create doubts than it is a meaningful touchpoint on the status of the research or the science behind the research. Validation, should it happen, will likely change everything.

Key though, there will also be many with long blades ready to give a big, dangerously pointy bear hug on success too...a congratulations, but we’ll get you - kind of response...